egtazic acid has been researched along with arecoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, P; Balapure, AK; Kondaiah, P; Rao, SG; Thangjam, GS | 1 |
| Chang, LS; Chen, YJ | 1 |
2 other study(ies) available for egtazic acid and arecoline
| Article | Year |
|---|---|
Regulation of extracellular matrix genes by arecoline in primary gingival fibroblasts requires epithelial factors.
Topics: Arecoline; Cell Line; Chelating Agents; Cholinergic Agonists; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Collagen Type IV; Collagen Type VI; Collagen Type VII; Down-Regulation; Egtazic Acid; Extracellular Matrix; Fibroblasts; Gingiva; Humans; Keratinocytes; Mouth Mucosa; Oral Submucous Fibrosis; Protein Isoforms; Protein Kinase C; Receptor, Muscarinic M3; Staurosporine; Transforming Growth Factor beta1; Transforming Growth Factor beta2 | 2009 |
Arecoline-induced death of human leukemia K562 cells is associated with surface up-modulation of TNFR2.
Topics: ADAM Proteins; Anthracenes; Arecoline; Calcium; Cell Death; Chelating Agents; Cholinergic Agonists; Egtazic Acid; Extracellular Signal-Regulated MAP Kinases; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; MAP Kinase Kinase 1; MAP Kinase Signaling System; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; RNA Interference; Tumor Necrosis Factor-alpha; Up-Regulation | 2012 |